Literature DB >> 29478516

Inflammatory Response During Myocardial Infarction.

Joaquim B Oliveira1, Alexandre A S M Soares1, Andrei C Sposito2.   

Abstract

The occlusion of a coronary artery by a thrombus generated on a ruptured atherosclerotic plaque has been pursued in the last decades as a determining event for the clinical outcome after myocardial infarction (MI). Yet, MI causes a cell death wave front, which triggers an inflammatory response to clear cellular debris, and which in excess can double the myocardial lesion and influence the clinical prognosis in the short and long term. Accordingly, proper, timely regulated inflammatory response has now been considered a second pivotal player in cardiac recovery after MI justifying the search for pharmacological strategies to modulate inflammatory effectors. This chapter reviews the key events and the main effectors of inflammation after myocardial ischemic insult, as well as the contribution of this phenomenon to the progression of atherosclerosis.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Inflammation; Myocardial infarction

Mesh:

Year:  2018        PMID: 29478516     DOI: 10.1016/bs.acc.2017.12.002

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  8 in total

1.  Macrophage M2 polarization induced by exosomes from adipose-derived stem cells contributes to the exosomal proangiogenic effect on mouse ischemic hindlimb.

Authors:  Dihan Zhu; Takerra K Johnson; Yang Wang; Miracle Thomas; Ky Huynh; Qinglin Yang; Vincent C Bond; Y Eugene Chen; Dong Liu
Journal:  Stem Cell Res Ther       Date:  2020-04-22       Impact factor: 6.832

2.  Protective Effect of Xinmailong Injection on Rats With Myocardial Infarction.

Authors:  Wei Zhang; Kailiang Li; Yu Ding; Jiefeng Ren; Haijun Wang; Quanjin Si
Journal:  Front Physiol       Date:  2021-01-13       Impact factor: 4.755

3.  New targets of morphine postconditioning protection of the myocardium in ischemia/reperfusion injury: Involvement of HSP90/Akt and C5a/NF-κB.

Authors:  Rong-Hui Tu; Dong-Xiao Wang; Guo-Qiang Zhong; Jian-Jun Meng; Hong Wen; Qi Bi; Yan He
Journal:  Open Med (Wars)       Date:  2021-10-18

Review 4.  Innate Lymphoid Cells and Myocardial Infarction.

Authors:  Wenling Yang; Jibin Lin; Jin Zhou; Yuqi Zheng; Shijiu Jiang; Shaolin He; Dazhu Li
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

5.  LuQi Formula Ameliorates Myocardial Fibrosis by Suppressing TLR4/MyD88/NF-κB Pathway and NLRP3 Inflammasome Activation in Mice with Myocardial Infarction.

Authors:  Xiaoqing Zhang; Huiyan Qu; Tao Yang; Qian Liu; Dandan Zhao; Wenrui Liu; Tian Wang; Hua Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-11       Impact factor: 2.629

6.  Dynamic regulation of HIF-1 signaling in the rhesus monkey heart after ischemic injury.

Authors:  Tao Wang; Ying Xiao; Jingyao Zhang; Fujia Jing; Guodan Zeng
Journal:  BMC Cardiovasc Disord       Date:  2022-09-11       Impact factor: 2.174

7.  Transfer RNA-derived small RNAs and their potential roles in the therapeutic heterogeneity of sacubitril/valsartan in heart failure patients after acute myocardial infarction.

Authors:  Jia Su; Ji Cheng; Yingchu Hu; Qinglin Yu; Zhenwei Li; Jiyi Li; Nan Zheng; Zhaoxia Zhang; Jin Yang; Xiaojing Li; Zeqin Zhang; Yong Wang; Keqi Zhu; Weiping Du; Xiaomin Chen
Journal:  Front Cardiovasc Med       Date:  2022-09-29

8.  Protective effects of Salidroside on cardiac function in mice with myocardial infarction.

Authors:  Pengsheng Chen; Jia Liu; Hongyun Ruan; Miaomiao Zhang; Peng Wu; Du Yimei; Bing Han
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.